STAT+: Pharmalittle: We’re reading about faster FDA approvals, access to experimental drugs in Montana, and more

Summary

The FDA is launching a pilot program to accelerate the timeline for drugmakers to initiate human testing of new products. This regulatory initiative aims to streamline the early-stage drug development process.